This study revealed that melatonin inhibits the TPA-induced MMP-9 expression of oral cancer HSC-3 and OECM-1 cells through ERK1/2 phosphorylation (Figure 3A). This evidence concerns the gene MAPK3 and lip and oral cavity carcinoma.